NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
December 30, 2024 — Muhdo Health partners with Rgentic in Turkey to distribute genetic testing kits, launching a dedicated Turkish-language website. The exclusive agreement opens doors for Muhdo to expand its presence in the health and wellness market.
December 29, 2024 — South Fork Instruments introduces Kemtrak disposable optical measurement cells for bioprocessing applications, offering precise and contamination-free solutions. These single-use cells address critical measurement needs in chromatographic separation, filtration, and protein concentration monitoring.
December 29, 2024 — Stonegate Capital Partners provides an update on Bio-Path Holdings, Inc. for Q3 2024, emphasizing the company's innovative drug candidates and breakthrough technology in cancer treatment. With a strong IP position and strategic relationships, Bio-Path is poised for success and potential growth in the biopharmaceutical industry.
December 29, 2024 — Kessler Topaz Meltzer & Check, LLP files securities class action lawsuit against Applied Therapeutics, Inc. for alleged misconduct. Investors who purchased securities during specific dates urged to take action before February 18, 2025. Learn more about the case and potential impact on the pharmaceutical industry.
December 28, 2024 — The 'Psychiatry: An Industry of Death' museum in Clearwater, hosted by CCHR, draws over 10,000 visitors and aims to raise awareness about the history of psychiatry and advocate for effective change in mental health laws.
December 27, 2024 — Clene (NASDAQ: CLNN) and its subsidiary, Clene Nanomedicine Inc., received FDA guidance for potential accelerated approval of their lead drug candidate CNM-Au8 in ALS. The guidance followed a Type C meeting where Clene presented additional clinical trial data and analyses. Clene plans to submit an NDA under the accelerated approval pathway in mid-2025.
December 26, 2024 — Learn about the securities class action lawsuit filed by Kessler Topaz Meltzer & Check, LLP against Applied Therapeutics, Inc. Allegations include failure to adhere to trial protocol for the drug candidate govorestat, posing a risk of FDA rejection. Investors have until February 18, 2025, to seek appointment as a lead plaintiff.
December 24, 2024 — Chia-Lin Simmons, CEO of LogicMark, discusses the launch of the new premiere safety smartphone, the Freedom Alert Max, in an interview with Benzinga’s All-Access. LogicMark is a leading provider of personal emergency response systems (PERS), health communications devices, and IoT technologies, aiming to create a connected care platform to keep at-risk populations safe.
December 24, 2024 — Diabetics Trust introduces a Transparency Pledge, setting a new standard in the industry for selling diabetic supplies. The initiative ensures fair payouts, fast payments, and a transparent process, addressing rising healthcare costs and promoting sustainability.
December 24, 2024 — Recent study in New South Wales, Australia reveals significant socioeconomic disparity in cancer patient life expectancy. Urgent need to address healthcare disparities and improve access to early detection, quality treatment, and survivorship care for all patients.
December 24, 2024 — New study in Biomedical Analysis reviews advancements in detection of circRNAs, highlighting their potential as cancer biomarkers. Crucial for understanding disease processes and improving diagnosis and prognosis.
December 24, 2024 — Researchers conduct a systematic review of conductive hydrogels, highlighting recent advancements in applications such as wearable sensors and electrical stimulation. Conductive hydrogels have emerged as a pivotal material for soft bioelectronics, particularly for applications requiring compatibility with human tissues.
December 19, 2024 — Boost your immune system with iron - a crucial nutrient for maintaining a healthy immune system, especially during cold and flu season. Learn about the important role of iron in supporting immune health and the benefits of a highly absorbable iron supplement like Ferosom.
December 23, 2024 — Dr. Yorell Manon-Matos launches the Dr. Yorell Manon Matos Grant for Healthcare Students, offering a $1,000 award to support undergraduate students pursuing careers in healthcare. The grant aims to encourage those with a passion for addressing the complex challenges facing the healthcare industry today.
December 21, 2024 — Alpha Behavioral Health introduces a Life Skills Development program to equip young adults in recovery with essential tools for independent living. Discover how this holistic approach prepares participants for a sustainable future and emphasizes community involvement for long-term success.
December 21, 2024 — Hawaii Island Recovery in Kailua-Kona, HI, offers specialized programs for veterans and their families, providing comprehensive care and support for lasting recovery. Learn about the innovative approach and holistic services provided by the center to address the unique challenges faced by veterans and their loved ones.
December 21, 2024 — Discover NorthStar Recovery Center's new evening IOP program in Southborough, MA, offering convenient addiction treatment services during evening hours. Learn how this expansion enhances the recovery support landscape in Massachusetts and provides individuals with a flexible option for comprehensive care.
December 21, 2024 — Discover LifeSpring Home Nutrition's new gluten-friendly meal selection, designed to cater to individuals with dietary restrictions while maintaining balanced nutrition. Learn how these meals support heart health and manage blood pressure, providing a delicious way to enjoy a gluten-free lifestyle.
December 20, 2024 — Leonhardt Ventures LLC granted exclusive patent for bioelectric stimulator, a significant advancement in regenerative medicine. The core platform technology will be applied to various medical applications, including heart and cardiovascular health, brain health, major organ regeneration, medical aesthetics, and cancer treatment.
December 20, 2024 — Cognition Therapeutics Inc. announced positive topline results of its exploratory phase 2 SHIMMER study for CT1812, its experimental orally delivered small molecule oligomer antagonist to treat dementia with Lewy bodies, showing potential breakthrough in treatment.